Sullivan D R
Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
J Cardiovasc Risk. 1994 Oct;1(3):212-6. doi: 10.1177/174182679400100305.
Our understanding of the pathophysiological role of lipoprotein (a) in cardiovascular disease and its clinical importance has improved, but there are still gaps in our knowledge and analytical performance that hinder the appropriate management of patients. Further information about the physiological functions of lipoprotein (a), if any, and its interactions with other risk factors is required.
我们对脂蛋白（a）在心血管疾病中的病理生理作用及其临床重要性的理解有所提高，但在知识和分析性能方面仍存在差距，这阻碍了对患者的适当管理。需要进一步了解脂蛋白（a）的生理功能（如果有的话）及其与其他危险因素的相互作用。
